NEW DELHI: Bharat Biotech affirmed that the recent death of a 42-year-old volunteer was not related to the vaccine.
Bhopal based man was one of the volunteers for Bharat Biotech's Covaxin trials, a vaccine against the novel Coronavirus disease (COVID-19).
He died recently due to cardiorespiratory failure and suspected poisoning.
Bharat Biotech said that all the criteria needed for the Phase III trial were met by the volunteer.
For seven days, after the vaccine, he did not show any side effects as per the reports. Volunteer passed away nine days after dosing and the preliminary investigation said that his death has nothing to do with dosing.